Japan start-up Innophys Co. is expanding overseas in nations that have aging populations to offer its wearable exoskeleton to support heavy lifting.
Set up by Tokyo University of Science professor Hiroshi Kobayashi, Innophys Co, hopes its products will be used in the care and farm fields in Europe, China, and South Korea, where similar age-related social issues occue.
Innophys Executive Officer Masaru Yoda said that with demand for assistive suits getting greater as populations age, they have a chance at being top in the world.
The firm has a domestic market share of about 70 percent. It sold around 20,000 Muscle Suit in April 2021 since launching it in 2014.
The exoskeletons support the arms and back.
They employ artificial muscles that are composed of rubber tubes covered in nylon mesh that expand when compressed air is added, creating a strong pulling force that can help with physically demanding manual activities and lessen back strain when lifting large goods.
The suit, which is worn like a backpack, can greatly reduce stress when performing heavy factory work, caregiving, and agricultural duties. It is also a useful tool for averting potential workplace mishaps.
Each item costs about 150,000 yen and weighs about 4 kg.
In 2020, Innophys began to expand into Taiwan, Hong Kong, and Macao. Currently, the company has sales representatives in 17 nations and areas, including China, South Korea, Germany, and France.


United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
GameStop Misses Q3 Revenue Estimates as Digital Shift Pressures Growth
Modi and Trump Hold Phone Call as India Seeks Relief From U.S. Tariffs Over Russian Oil Trade
SoftBank Eyes Switch Inc as It Pushes Deeper Into AI Data Center Expansion
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Wall Street Futures Slip as Oracle Earnings Miss Reignites AI Spending Concerns
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs
Hong Kong Cuts Base Rate as HKMA Follows U.S. Federal Reserve Move
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
S&P 500 Slides as AI Chip Stocks Tumble, Cooling Tech Rally
Fed’s Dovish Tone Sends Dollar Lower as Markets Price In More Rate Cuts
Fed Near Neutral Signals Caution Ahead, Shifting Focus to Fixed Income in 2026 



